Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2015

Open Access 01-12-2015 | Research

An approach to prioritization of medical devices in low-income countries: an example based on the Republic of South Sudan

Authors: Richard J Lilford, Samantha L Burn, Karin D Diaconu, Peter Lilford, Peter J Chilton, Victoria Bion, Carole Cummins, Semira Manaseki-Holland

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2015

Login to get access

Abstract

Background

Efficient and evidence-based medical device and equipment prioritization is of particular importance in low-income countries due to constraints in financing capacity, physical infrastructure and human resource capabilities.

Methods

This paper outlines a medical device prioritization method developed in first instance for the Republic of South Sudan. The simple algorithm offered here is a starting point for procurement and selection of medical devices and can be regarded as a screening test for those that require more labour intensive health economic modelling.

Conclusions

A heuristic method, such as the one presented here, is appropriate for reaching many medical device prioritization decisions in low-income settings. Further investment and purchasing decisions that cannot be reached so simply require more complex health economic modelling approaches.
Appendix
Available only for authorised users
Literature
1.
Ministry of Health, G. of S. S., Southern Sudan Commission for Census, S. and E. Southern Sudan Household Health Survey. 2006;304.
2.
Ministry of Health, G. of S. S. The basic package of health and nutrition services in secondary and tertiary health care. 2006;43.
3.
Ministry of Finance and Economic Planning South Sudan. Republic of South Sudan Donor Book. 2012;152.
4.
Achiek M, Lado D. Mapping the specialist medical workforce for Southern Sudan: devising ways for capacity building. South Sudan Med J. 2010;3(2):6–9.
5.
National Bureau of Statistics, S. S. South Sudan Statistical Yearbook. 2011;67.
6.
World Health Organization. List of medical devices by health care facility Health Post - Outpatient. 2010.
7.
World Health Organization. List of medical devices by health care facility Specialized Hospital - Diagnostic. 2010.
8.
World Health Organization, John Snow Inc., World Bank, PATH, United Nations Population Fund, Population Action International. Interagency List of Essential Medical Devices for Reproductive Health. 2008.
9.
World Health Organization. Guidance for countries on the specifications for managing TB laboratory equipments and supplies. 2011.
10.
Musgrove P, Fox-Rushby J. Disease Control Priorities: Chapter 15 Cost-Effectiveness Analysis for Priority Setting. In Disease Control Priorities in Developing Countries (2nd Edition). 2006;p. 271–286.
11.
Baltussen R, Floyd K, Dye C. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ (Clin Res Ed). 2005;331(7529):1364. doi:10.1136/bmj.38645.660093.68.CrossRef
12.
Borras C, PAHO, WHO. Organization, Development, Quality Assurance and Radiation Protection in Radiology Services: Imaging and Radiation Therapy. 1997.
13.
World Health Organization. Core Medical Equipment. 2011.
14.
World Health Organization. Medical devices: Managing the Mismatch (An outcome of the Priority Medical Devices project). 2010.
15.
Keller JP, ECRI. Instructions included? Materials management in Health Care. 2010;26–9.
16.
Perry L, Malkin R. Effectiveness of medical equipment donations to improve health systems: how much medical equipment is broken in the developing world? Med Biol Eng Comput. 2011;49(7):719–22. doi:10.1007/s11517-011-0786-3.PubMedCrossRef
17.
World Health Organization. (n.d.). Procurement process resource guide WHO Medical device technical series. 2011.
18.
Temple-Bird C, Kaur M, Lenel A, Kawohl W. How to manage series for healthcare technology: Guide 5 How to Organize the Maintenance of Your Healthcare Technology. TALC. 2005.
19.
20.
van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. Int J Obstet Gynaecol. 2007;114(6):664–75. doi:10.1111/j.1471-0528.2007.01326.x.CrossRef
21.
22.
Yasmin F, Farrukh R, Kamal F. Efficacy of pipelle as a tool for endometrial biopsy. 2007;23,12–5.
23.
Fakhar S, Saeed G, Khan A, Alam A. Validity of pipelle endometrial sampling in patients with abnormal uterine bleeding. Ann Saudi Med. 2008;28(3):188–91.PubMedCrossRef
24.
Shillcutt SD, Walker DG, Goodman CA, Mills AJ. Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. PharmacoEconomics. 2009;27(11):903–17. doi:10.2165/10899580-000000000-00000.PubMedCentralPubMedCrossRef
25.
WHO CHOICE Collaboration. WHO Guide to Cost-Effectiveness Analysis: Making Choices in Health. (T. Tan-Torres, R. Baltussen, T. Adam, R. Hutubessy, A. Acharya, D. B. Evans, & C. J. L. Murray, Eds.). World Health Organization. 2003;329
26.
Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158–68. doi:10.1056/NEJMsa044278.PubMedCrossRef
27.
28.
29.
Laxminarayan R, Chow J, Shahid-salles SA. Chapter 2 Intervention Cost-Effectiveness: Overview of Main Messages. In Disease Control Priorities in Developing Countries (2nd Edition). 2006;35–86.
30.
Burn SL, Chilton PJ, Gawande AA, Lilford RJ. Peri-operative pulse oximetry in low-income countries: a cost – effectiveness analysis. Bull World Health Organ. 2014; 92(12):858-67
31.
Sorenson, C., Drummond, M., & Kanavos, P. Ensuring value for money: The role of health technology assessment in the European Union. 2007;1–179.
32.
World Health Organization. WHO: Medical Device Technical Series Development of medical device policies. 2011.
33.
Teerawattananon Y, Mugford M. Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study. Cost Effectiveness Res Allocation: C/E. 2005;3:10. doi:10.1186/1478-7547-3-10.CrossRef
34.
Ribeiro RA, Stella SF, Camey SA, Zimerman LI, Pimentel M, Rohde LE, et al. Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector. Value Health. 2010;13(2):160–8. doi:10.1111/j.1524-4733.2009.00608.x.PubMedCrossRef
35.
36.
37.
Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Effectiveness Res Allocation. 2006;4:14. doi:10.1186/1478-7547-4-14.CrossRef
38.
Cosh E, Girling A, Lilford R, McAteer H, Young T. Investing in new medical technologies: a decision framework. J Commer Biotechnol. 2007;13(4):263–71. doi:10.1057/palgrave.jcb.3050062.CrossRef
Metadata
Title
An approach to prioritization of medical devices in low-income countries: an example based on the Republic of South Sudan
Authors
Richard J Lilford
Samantha L Burn
Karin D Diaconu
Peter Lilford
Peter J Chilton
Victoria Bion
Carole Cummins
Semira Manaseki-Holland
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2015
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/s12962-014-0027-3

Other articles of this Issue 1/2015

Cost Effectiveness and Resource Allocation 1/2015 Go to the issue

Research

Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin

Research

Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study

Research

Efficiency of private and public primary health facilities accredited by the National Health Insurance Authority in Ghana

Research

Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania

Research

Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain

Research

The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims